Shanghai Haoyuan Chemexpress Co., Ltd. (SHA:688131)

Market Cap	14.59B +58.4%
Revenue (ttm)	2.87B +26.3%
Net Income	247.77M +22.9%
EPS	1.17 +21.9%
Shares Out	212.10M
PE Ratio	58.79
Forward PE	35.28
Dividend	0.23 (0.34%)
Ex-Dividend Date	Oct 22, 2025

Volume	2,871,469
Average Volume	3,524,121
Open	68.26
Previous Close	68.79
Day's Range	66.41 - 68.77
52-Week Range	31.80 - 90.58
Beta	0.72
RSI	51.34
Earnings Date	Apr 23, 2026

About SHA:688131

Shanghai Haoyuan Chemexpress Co., Ltd. researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs. The company offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2006
• Employees: 3,826
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688131

Financial Performance

In 2025, SHA:688131's revenue was 2.87 billion, an increase of 26.35% compared to the previous year's 2.27 billion. Earnings were 247.77 million, an increase of 22.91%.